9-61191466-G-A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_015667.2(SPATA31A7):​c.203G>A​(p.Arg68Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000315 in 1,272,852 control chromosomes in the GnomAD database, including 99 homozygotes. In-silico tool predicts a benign outcome for this variant. 7/9 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R68W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00052 ( 20 hom., cov: 17)
Exomes 𝑓: 0.00032 ( 99 hom. )
Failed GnomAD Quality Control

Consequence

SPATA31A7
NM_015667.2 missense

Scores

7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.50
Variant links:
Genes affected
SPATA31A7 (HGNC:32007): (SPATA31 subfamily A member 7) Predicted to be involved in cell differentiation and spermatogenesis. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.039848983).
BS2
High Homozygotes in GnomAdExome4 at 99 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPATA31A7NM_015667.2 linkc.203G>A p.Arg68Gln missense_variant Exon 2 of 4 ENST00000619167.2 NP_056482.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPATA31A7ENST00000619167.2 linkc.203G>A p.Arg68Gln missense_variant Exon 2 of 4 1 NM_015667.2 ENSP00000484807.1 Q8IWB4

Frequencies

GnomAD3 genomes
AF:
0.000532
AC:
62
AN:
116500
Hom.:
20
Cov.:
17
show subpopulations
Gnomad AFR
AF:
0.000108
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00248
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000114
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000438
Gnomad OTH
AF:
0.00319
GnomAD2 exomes
AF:
0.0000170
AC:
4
AN:
235084
AF XY:
0.0000235
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000303
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000186
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000315
AC:
401
AN:
1272852
Hom.:
99
Cov.:
30
AF XY:
0.000285
AC XY:
180
AN XY:
631618
show subpopulations
African (AFR)
AF:
0.000200
AC:
5
AN:
25012
American (AMR)
AF:
0.00132
AC:
50
AN:
37900
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22446
East Asian (EAS)
AF:
0.000156
AC:
5
AN:
32092
South Asian (SAS)
AF:
0.0000155
AC:
1
AN:
64566
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47876
Middle Eastern (MID)
AF:
0.00126
AC:
5
AN:
3982
European-Non Finnish (NFE)
AF:
0.000290
AC:
286
AN:
987370
Other (OTH)
AF:
0.000949
AC:
49
AN:
51608
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
12
23
35
46
58
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000523
AC:
61
AN:
116552
Hom.:
20
Cov.:
17
AF XY:
0.000586
AC XY:
33
AN XY:
56356
show subpopulations
African (AFR)
AF:
0.000107
AC:
3
AN:
27936
American (AMR)
AF:
0.00247
AC:
28
AN:
11324
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2860
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3270
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2824
European-Finnish (FIN)
AF:
0.000114
AC:
1
AN:
8762
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
224
European-Non Finnish (NFE)
AF:
0.000421
AC:
24
AN:
57028
Other (OTH)
AF:
0.00317
AC:
5
AN:
1576
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000674
Hom.:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 13, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.203G>A (p.R68Q) alteration is located in exon 2 (coding exon 2) of the SPATA31A7 gene. This alteration results from a G to A substitution at nucleotide position 203, causing the arginine (R) at amino acid position 68 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_noAF
Benign
-0.98
CADD
Benign
2.7
DANN
Benign
0.75
DEOGEN2
Benign
0.022
T
LIST_S2
Benign
0.44
T
MetaRNN
Benign
0.040
T
PhyloP100
-1.5
Sift4G
Benign
0.42
T
Vest4
0.10
gMVP
0.14

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Loading publications...

Other links and lift over

dbSNP: rs370437389; hg19: chr9-65508180; API